tacrine   Click here for help

GtoPdb Ligand ID: 6687

Synonyms: CI-970 | Cognex® | tetrahydroaminoacridine
Approved drug PDB Ligand
tacrine is an approved drug (FDA (1993))
Compound class: Synthetic organic
Comment: Tacrine is a dual inhibitor of butyrylcholine esterase (P06276) and acetylcholinesterase (P22303). Marketed formulations may contain tacrine hydrochloride (PubChem CID 2723754).
Click here for help
2D Structure
Click here for help
Click here for structure editor
Physico-chemical Properties
Click here for help
Hydrogen bond acceptors 2
Hydrogen bond donors 1
Rotatable bonds 0
Topological polar surface area 38.91
Molecular weight 198.12
XLogP 2.23
No. Lipinski's rules broken 0
SMILES / InChI / InChIKey
Click here for help
Canonical SMILES Nc1c2CCCCc2nc2c1cccc2
Isomeric SMILES Nc1c2CCCCc2nc2c1cccc2
InChI InChI=1S/C13H14N2/c14-13-9-5-1-3-7-11(9)15-12-8-4-2-6-10(12)13/h1,3,5,7H,2,4,6,8H2,(H2,14,15)
InChI Key YLJREFDVOIBQDA-UHFFFAOYSA-N
No information available.
Summary of Clinical Use Click here for help
Tacrine is used to treat mild dementia caused by Alzheimer's disease and other central nervous system disorders. Use has been discontinued in the US, as this drug has been superseded by alternative cholinesterase inhibitors.
Mechanism Of Action and Pharmacodynamic Effects Click here for help
Tacrine prevents the breakdown of acetylcholine, ameliorating the effect of lower levels of this compound often observed in patients with dementia. Acetylcholine is important for the processes of memory, thinking, and reasoning.
External links Click here for help